Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
18,933,281
-
Shares change
-
+504,284
-
Total reported value, excl. options
-
$115,491,000
-
Value change
-
+$2,927,862
-
Number of buys
-
23
-
Number of sells
-
-16
-
Price
-
$6.10
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2016
56 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q4 2016.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,933,281 shares
.
Largest 10 shareholders include NEA Management Company, LLC (8,584,128 shares), BVF INC/IL (2,826,282 shares), WELLINGTON MANAGEMENT GROUP LLP (2,799,917 shares), FRANKLIN RESOURCES INC (999,979 shares), SPHERA FUNDS MANAGEMENT LTD. (745,796 shares), VANGUARD GROUP INC (424,444 shares), BlackRock Fund Advisors (397,828 shares), BAKER BROS. ADVISORS LP (381,235 shares), Cormorant Asset Management, LLC (287,031 shares), and Candriam Luxembourg S.C.A. (160,000 shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.